89 related articles for article (PubMed ID: 1834847)
21. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength.
Bellemann P; Ferry D; Lübbecke F; Glossmann H
Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804
[TBL] [Abstract][Full Text] [Related]
22. o-Isothiocyanate dihydropyridine (oNCS-DHP), a long-acting, reversible inhibitor of the Ca++ channel.
Kozlowski R; Ehrhard P; Fischli W; Osterrieder W; Holck M
J Pharmacol Exp Ther; 1986 Sep; 238(3):1084-91. PubMed ID: 2427686
[TBL] [Abstract][Full Text] [Related]
23. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
[TBL] [Abstract][Full Text] [Related]
24. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
[TBL] [Abstract][Full Text] [Related]
25. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.
Greenberg DA; Carpenter CL; Messing RO
J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685
[TBL] [Abstract][Full Text] [Related]
26. Differential roles of dihydropyridine calcium antagonist nifedipine, nitrendipine and amlodipine on gentamicin-induced renal tubular toxicity in rats.
Li J; Li QX; Xie XF; Ao Y; Tie CR; Song RJ
Eur J Pharmacol; 2009 Oct; 620(1-3):97-104. PubMed ID: 19698708
[TBL] [Abstract][Full Text] [Related]
27. A novel high affinity class of Ca2+ channel blockers.
Qar J; Barhanin J; Romey G; Henning R; Lerch U; Oekonomopulos R; Urbach H; Lazdunski M
Mol Pharmacol; 1988 Apr; 33(4):363-9. PubMed ID: 2965787
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of [3H]nitrendipine binding sites in rat spinal cord.
Gandhi VC; Jones DJ
J Pharmacol Exp Ther; 1988 Nov; 247(2):473-80. PubMed ID: 2460614
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
Janis RA; Sarmiento JG; Maurer SC; Bolger GT; Triggle DJ
J Pharmacol Exp Ther; 1984 Oct; 231(1):8-15. PubMed ID: 6208356
[TBL] [Abstract][Full Text] [Related]
30. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.
Bolger GT; Marcus KA; Daly JW; Skolnick P
J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279
[TBL] [Abstract][Full Text] [Related]
31. The pharmacological profile of amlodipine in relation to ischaemic heart disease.
Burges RA
Postgrad Med J; 1991; 67 Suppl 3():S9-15. PubMed ID: 1836872
[TBL] [Abstract][Full Text] [Related]
32. Slow dissociation of long-acting Ca2+ antagonist amlodipine from 3H-PN200-110 binding sites in membranes of rat hearts and brains.
Sugiyama K; Qu YL; Maruyama K; Hattori K; Watanabe K; Nagatomo T
Biol Pharm Bull; 1996 Feb; 19(2):195-8. PubMed ID: 8850304
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
34. Specific high affinity binding of the calcium channel antagonist, [3H]nitrendipine, to rat liver microsomes.
Gopalakrishnan V; Triggle CR
Can J Physiol Pharmacol; 1984 Sep; 62(9):1249-52. PubMed ID: 6498637
[TBL] [Abstract][Full Text] [Related]
35. Profiles of calcium antagonists in cardiovascular disease with special reference to second-generation agents and amlodipine.
Opie LH
Postgrad Med J; 1991; 67 Suppl 5():S2-8. PubMed ID: 1666430
[TBL] [Abstract][Full Text] [Related]
36. Relaxation of potassium chloride-induced contractions by amlodipine and its interaction with the 1,4-dihydropyridine-binding site in pig coronary artery.
Matlib MA
Am J Cardiol; 1989 Nov; 64(17):51I-57I. PubMed ID: 2530885
[TBL] [Abstract][Full Text] [Related]
37. The Ca2+ -antagonist and binding properties of the phenylalkylamine, anipamil.
Dillon JS; Nayler WG
Br J Pharmacol; 1988 May; 94(1):253-63. PubMed ID: 2456811
[TBL] [Abstract][Full Text] [Related]
38. Pharmacologic profile of amlodipine.
Burges RA; Dodd MG; Gardiner DG
Am J Cardiol; 1989 Nov; 64(17):10I-18I; discussion 18I-20I. PubMed ID: 2554708
[TBL] [Abstract][Full Text] [Related]
39. The effect of hypoxia and of energy depletion on 1,4-dihydropyridine binding sites in rat cardiac membrane fragments.
Gu XH; Dillon JS; Nayler WG
Biochem Pharmacol; 1989 Jun; 38(12):1897-907. PubMed ID: 2742598
[TBL] [Abstract][Full Text] [Related]
40. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.
Gu XH; Dillon JS; Nayler WG
J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
